Engineering T cells with hypoxia-inducible chimeric antigen receptor (HiCAR) for selective tumor killing
Abstract Chimeric antigen receptor-modified T cells (CAR-T cells) have shown good effects in the treatment of hematologic cancers; however, they may cause on-target off-tumor toxicity because of minimal expression of tumor-associated antigens (TAAs) on normal tissues, particularly in the context of...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMC
2020-10-01
|
| Schriftenreihe: | Biomarker Research |
| Schlagworte: | |
| Online-Zugang: | http://link.springer.com/article/10.1186/s40364-020-00238-9 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
